The overexpression of NaV1.7 was exclusively detected in MTC over other neuroendocrine tumors (NETs) such as pancreatic NET (BON cells) and pulmonary NET (H727 cells). This evidence concerns the gene SCN9A and medullary thyroid gland carcinoma.